Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Mar-Apr;30(2):125-128.
doi: 10.4103/ijn.IJN_271_18. Epub 2020 Feb 19.

Amyloid Goiter in a Patient with Rheumatoid Arthritis and End-Stage Renal Disease

Affiliations
Case Reports

Amyloid Goiter in a Patient with Rheumatoid Arthritis and End-Stage Renal Disease

Ayşe Şeker et al. Indian J Nephrol. 2020 Mar-Apr.

Abstract

The association between amyloidosis and collagen vascular diseases, such as rheumatoid arthritis (RA) is well-documented. Amyloid goiter is an extremely rare pathologic condition caused by a massive amyloid infiltration of the thyroid tissue. Our patient had been diagnosed with RA 20 years ago and was on hemodialysis for 7 years. He was assessed for decreased appetite, dysphagia, and nausea during the hemodialysis. On physical examination, the thyroid was diffusely enlarged with multiple nodules. He was biochemically euthyroid. Ultrasound of the thyroid gland showed multinodular goiter. A total thyroidectomy was performed. Histopathological examination showed dilated follicles surrounded by abundant homogeneous substance that stained positive with Congo red. The patient was reported as amyloid goiter. Complaints of the patient improved after the surgery. In the literature, amyloid goiter with RA in a hemodialysis patient is very rare. Amyloid goiter should be considered if there is a rapid thyromegaly causing pressure symptoms in the background of any disease with chronic inflammation.

Keywords: Amyloid goiter; hemodialysis patient; rheumatoid arthritis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Accumulation of common extracellular and acellular homogeneous eosinophilic amorphous proteinaceous material (amyloid) between follicles in thyroid parenchyma with occasional mature fat deposits (arrows). Enlarged and elongated colloid-containing thyroid follicles with squamous metaplasia. (Hematoxylin Eosin 40X)
Figure 2
Figure 2
Thyroid follicles and blood vessels are surrounded by the accumulation of amyloid deposits, which are metachromatic-stained with Crystal Violet (arrows) (Crystal Violet 40X)

Similar articles

Cited by

References

    1. Cohen AS. Proteins of the systemic amyloidoses. Curr Opin Rheumatol. 1994;6:55–67. - PubMed
    1. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337:898–909. - PubMed
    1. Villa F, Dionigi G, Tanda ML, Rovera F, Boni L. Amyloid goiter. Int J Surg. 2008;6:16–8. - PubMed
    1. Gomez-Casanovas E, Sanmarti R, Sole M, Canate JD, Munoz-Gomez J. The clinical significance of amyloid fat deposit in rheumatoid arthritis. A systemic long-term follow up study using abdominal fat aspiration. Arthritis Rheum. 2001;44:66–72. - PubMed
    1. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001;358:24–29. - PubMed

Publication types